The current leadership team at Synthetic Genomics has a wide range of experience in both the public and private sectors. They have held positions at various companies, such as Halozyme Therapeutics, Inc. and CareFusion. They also have a wealth of experience in areas such as M&A, integration, and separation consulting. In addition, the team is highly educated, with degrees from Wesleyan University and the Questrom School of Business at Boston University.
View all